We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Nixes Deal In Sun Pharma Eloxatin Suit

Law360 (December 23, 2010, 8:19 PM EST) -- Sun Pharmaceutical Industries Inc. could be one step closer to selling a generic version of the colon cancer drug Eloxatin after convincing a federal appeals court to vacate and remand a...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.